

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 9.48863927 |
| 2 | cardiac right ventricle morphogenesis (GO:0003215) | 9.19378095 |
| 3 | N-acetylneuraminate metabolic process (GO:0006054) | 9.14374035 |
| 4 | cellular response to lithium ion (GO:0071285) | 8.77900094 |
| 5 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 7.60889327 |
| 6 | regulation of MHC class II biosynthetic process (GO:0045346) | 7.50861463 |
| 7 | centriole replication (GO:0007099) | 7.44230171 |
| 8 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 7.32238985 |
| 9 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 7.26583197 |
| 10 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.21045135 |
| 11 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.21045135 |
| 12 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 6.96332592 |
| 13 | mitochondrion transport along microtubule (GO:0047497) | 6.96332592 |
| 14 | positive regulation of protein deacetylation (GO:0090312) | 6.90635686 |
| 15 | regulation of chemokine biosynthetic process (GO:0045073) | 6.87158493 |
| 16 | negative regulation of phagocytosis (GO:0050765) | 6.69226724 |
| 17 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 6.55614534 |
| 18 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 6.50786667 |
| 19 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 6.50786667 |
| 20 | regulation of growth of symbiont in host (GO:0044126) | 6.50786667 |
| 21 | negative regulation of growth of symbiont in host (GO:0044130) | 6.50786667 |
| 22 | amino sugar catabolic process (GO:0046348) | 6.47699123 |
| 23 | response to parathyroid hormone (GO:0071107) | 6.42736111 |
| 24 | establishment of mitochondrion localization (GO:0051654) | 6.30116940 |
| 25 | base-excision repair, AP site formation (GO:0006285) | 6.13006675 |
| 26 | microglial cell activation (GO:0001774) | 6.04132494 |
| 27 | purine deoxyribonucleotide catabolic process (GO:0009155) | 6.02700871 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.79785118 |
| 29 | response to lithium ion (GO:0010226) | 5.63950309 |
| 30 | embryonic camera-type eye development (GO:0031076) | 5.54334328 |
| 31 | neutrophil mediated immunity (GO:0002446) | 5.51230593 |
| 32 | reactive oxygen species biosynthetic process (GO:1903409) | 5.45543348 |
| 33 | enteric nervous system development (GO:0048484) | 5.34284669 |
| 34 | thalamus development (GO:0021794) | 5.33444775 |
| 35 | macrophage chemotaxis (GO:0048246) | 5.30143012 |
| 36 | cytokinetic process (GO:0032506) | 5.29299390 |
| 37 | centriole assembly (GO:0098534) | 5.22055548 |
| 38 | heme biosynthetic process (GO:0006783) | 5.12283855 |
| 39 | N-acetylglucosamine metabolic process (GO:0006044) | 5.01319408 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.99003922 |
| 41 | defense response to fungus (GO:0050832) | 4.98527594 |
| 42 | regulation of histone deacetylation (GO:0031063) | 4.88379706 |
| 43 | negative regulation of interleukin-2 production (GO:0032703) | 4.81048025 |
| 44 | tooth mineralization (GO:0034505) | 4.80975754 |
| 45 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 4.79160026 |
| 46 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 4.79160026 |
| 47 | glial cell migration (GO:0008347) | 4.67188274 |
| 48 | smooth muscle cell differentiation (GO:0051145) | 4.63010597 |
| 49 | negative regulation of histone acetylation (GO:0035067) | 4.62592602 |
| 50 | induction of positive chemotaxis (GO:0050930) | 4.55746979 |
| 51 | angiotensin maturation (GO:0002003) | 4.53111147 |
| 52 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 4.49482865 |
| 53 | protein maturation by protein folding (GO:0022417) | 4.48890331 |
| 54 | heart field specification (GO:0003128) | 4.42629548 |
| 55 | secondary heart field specification (GO:0003139) | 4.42629548 |
| 56 | cell migration involved in heart development (GO:0060973) | 4.39487013 |
| 57 | hair cycle (GO:0042633) | 4.38954820 |
| 58 | molting cycle (GO:0042303) | 4.38954820 |
| 59 | behavioral response to nicotine (GO:0035095) | 4.34786263 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 4.33194962 |
| 61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.25758551 |
| 62 | regulation of fatty acid transport (GO:2000191) | 4.20414497 |
| 63 | cardiac ventricle morphogenesis (GO:0003208) | 4.18614914 |
| 64 | folic acid metabolic process (GO:0046655) | 4.17077274 |
| 65 | bone trabecula formation (GO:0060346) | 4.14270223 |
| 66 | killing of cells of other organism (GO:0031640) | 4.08978464 |
| 67 | disruption of cells of other organism (GO:0044364) | 4.08978464 |
| 68 | fatty acid homeostasis (GO:0055089) | 4.07224911 |
| 69 | patterning of blood vessels (GO:0001569) | 4.05230929 |
| 70 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.01485259 |
| 71 | myeloid leukocyte mediated immunity (GO:0002444) | 3.96232170 |
| 72 | peripheral nervous system neuron development (GO:0048935) | 3.94387814 |
| 73 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 3.94234394 |
| 74 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.91574866 |
| 75 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.88518297 |
| 76 | layer formation in cerebral cortex (GO:0021819) | 3.87429436 |
| 77 | synaptic vesicle maturation (GO:0016188) | 3.87238380 |
| 78 | ribosomal small subunit biogenesis (GO:0042274) | 3.85843769 |
| 79 | cellular response to cadmium ion (GO:0071276) | 3.85394130 |
| 80 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.83446883 |
| 81 | response to misfolded protein (GO:0051788) | 3.78752998 |
| 82 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.77264794 |
| 83 | cardiac chamber morphogenesis (GO:0003206) | 3.76343737 |
| 84 | I-kappaB phosphorylation (GO:0007252) | 3.73839332 |
| 85 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.73429609 |
| 86 | regulation of protein import into nucleus, translocation (GO:0033158) | 3.71533410 |
| 87 | negative regulation of protein localization to cell surface (GO:2000009) | 3.70017689 |
| 88 | response to fungus (GO:0009620) | 3.65834193 |
| 89 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.64421019 |
| 90 | vocalization behavior (GO:0071625) | 3.62156427 |
| 91 | opsonization (GO:0008228) | 3.60038014 |
| 92 | cell migration in hindbrain (GO:0021535) | 3.57830367 |
| 93 | response to folic acid (GO:0051593) | 3.55189139 |
| 94 | locomotory exploration behavior (GO:0035641) | 3.54829949 |
| 95 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.54449858 |
| 96 | removal of superoxide radicals (GO:0019430) | 3.54082295 |
| 97 | cellular response to superoxide (GO:0071451) | 3.54082295 |
| 98 | cellular response to oxygen radical (GO:0071450) | 3.54082295 |
| 99 | regulation of sequestering of triglyceride (GO:0010889) | 3.51614749 |
| 100 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.48801037 |
| 101 | regulation of sarcomere organization (GO:0060297) | 3.48178366 |
| 102 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.48167797 |
| 103 | regulation of synapse structural plasticity (GO:0051823) | 3.47543860 |
| 104 | tetrapyrrole biosynthetic process (GO:0033014) | 3.47420687 |
| 105 | mitochondrion localization (GO:0051646) | 3.43315458 |
| 106 | response to oxygen radical (GO:0000305) | 3.43158399 |
| 107 | deoxyribonucleotide catabolic process (GO:0009264) | 3.40677042 |
| 108 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.36384235 |
| 109 | heme metabolic process (GO:0042168) | 3.36022014 |
| 110 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.33528036 |
| 111 | positive regulation of bone mineralization (GO:0030501) | 3.30319822 |
| 112 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 3.30230345 |
| 113 | regulation of protein deacetylation (GO:0090311) | 3.28312562 |
| 114 | endocardial cushion morphogenesis (GO:0003203) | 3.24943627 |
| 115 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.24679346 |
| 116 | low-density lipoprotein particle remodeling (GO:0034374) | 3.22118497 |
| 117 | nodal signaling pathway (GO:0038092) | 3.21267349 |
| 118 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 3.20374579 |
| 119 | positive regulation of glomerulus development (GO:0090193) | 3.20290351 |
| 120 | cardiac ventricle formation (GO:0003211) | 3.19631326 |
| 121 | negative regulation of protein acetylation (GO:1901984) | 3.19385022 |
| 122 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.16364731 |
| 123 | positive regulation of hair follicle development (GO:0051798) | 3.15585380 |
| 124 | positive regulation of hair cycle (GO:0042635) | 3.15585380 |
| 125 | deoxyribose phosphate catabolic process (GO:0046386) | 3.12643343 |
| 126 | sympathetic nervous system development (GO:0048485) | 3.11950440 |
| 127 | signal complex assembly (GO:0007172) | 3.11593943 |
| 128 | response to food (GO:0032094) | 3.11501443 |
| 129 | protein localization to synapse (GO:0035418) | 3.09826996 |
| 130 | hematopoietic stem cell proliferation (GO:0071425) | 3.08985009 |
| 131 | dendritic spine morphogenesis (GO:0060997) | 3.07543298 |
| 132 | positive regulation of biomineral tissue development (GO:0070169) | 3.07091135 |
| 133 | regulation of glycolytic process (GO:0006110) | 3.07014334 |
| 134 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.03677885 |
| 135 | apoptotic process involved in morphogenesis (GO:0060561) | 3.03468878 |
| 136 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.02024374 |
| 137 | dendrite morphogenesis (GO:0048813) | 2.99741507 |
| 138 | cardiac chamber formation (GO:0003207) | 2.99454112 |
| 139 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.97969914 |
| 140 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.95184093 |
| 141 | S-adenosylmethionine metabolic process (GO:0046500) | 2.94238873 |
| 142 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.92606277 |
| 143 | negative regulation of cell cycle arrest (GO:0071157) | 2.92006863 |
| 144 | cell communication by electrical coupling (GO:0010644) | 2.90683658 |
| 145 | chaperone-mediated protein transport (GO:0072321) | 2.89123077 |
| 146 | glutamate secretion (GO:0014047) | 2.89084656 |
| 147 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.88237865 |
| 148 | response to nerve growth factor (GO:1990089) | 2.88237865 |
| 149 | cartilage morphogenesis (GO:0060536) | 2.87722184 |
| 150 | polyol transport (GO:0015791) | 2.87299227 |
| 151 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.87190998 |
| 152 | neuron recognition (GO:0008038) | 2.86640880 |
| 153 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.85964566 |
| 154 | triglyceride biosynthetic process (GO:0019432) | 2.83696317 |
| 155 | regulation of synaptic vesicle transport (GO:1902803) | 2.83134848 |
| 156 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.83133740 |
| 157 | organelle transport along microtubule (GO:0072384) | 2.82460150 |
| 158 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.81756536 |
| 159 | regulation of cardioblast proliferation (GO:0003264) | 2.81756536 |
| 160 | activin receptor signaling pathway (GO:0032924) | 2.81586332 |
| 161 | porphyrin-containing compound metabolic process (GO:0006778) | 2.81224261 |
| 162 | hydrogen peroxide catabolic process (GO:0042744) | 2.80746091 |
| 163 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.80149493 |
| 164 | neuron cell-cell adhesion (GO:0007158) | 2.79390387 |
| 165 | phenol-containing compound catabolic process (GO:0019336) | 2.79163524 |
| 166 | specification of organ identity (GO:0010092) | 2.78832968 |
| 167 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.77598995 |
| 168 | UV protection (GO:0009650) | 2.77565454 |
| 169 | response to superoxide (GO:0000303) | 2.76466554 |
| 170 | heart trabecula morphogenesis (GO:0061384) | 2.76130076 |
| 171 | glucosamine-containing compound metabolic process (GO:1901071) | 2.74658179 |
| 172 | exploration behavior (GO:0035640) | 2.73665544 |
| 173 | postsynaptic membrane organization (GO:0001941) | 2.73341727 |
| 174 | negative regulation of microtubule polymerization (GO:0031115) | 2.69581906 |
| 175 | positive regulation of muscle hypertrophy (GO:0014742) | 2.69158177 |
| 176 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.69158177 |
| 177 | protein heterotrimerization (GO:0070208) | 2.69152140 |
| 178 | synaptic vesicle exocytosis (GO:0016079) | 2.67223620 |
| 179 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.65751594 |
| 180 | 4-hydroxyproline metabolic process (GO:0019471) | 2.64620071 |
| 181 | neurotransmitter secretion (GO:0007269) | 2.62453312 |
| 182 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.62369251 |
| 183 | cardiac muscle contraction (GO:0060048) | 2.61781970 |
| 184 | cellular respiration (GO:0045333) | 2.61387189 |
| 185 | positive regulation of synapse maturation (GO:0090129) | 2.57318675 |
| 186 | response to water (GO:0009415) | 2.56262769 |
| 187 | regulation of synaptic plasticity (GO:0048167) | 2.56257829 |
| 188 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.55893129 |
| 189 | regulation of DNA-templated transcription, initiation (GO:2000142) | 2.54198546 |
| 190 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.50166576 |
| 191 | nucleobase catabolic process (GO:0046113) | 2.50126180 |
| 192 | positive regulation of osteoblast differentiation (GO:0045669) | 2.48434263 |
| 193 | gamma-aminobutyric acid transport (GO:0015812) | 2.48303796 |
| 194 | hemoglobin metabolic process (GO:0020027) | 2.48054786 |
| 195 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.47505179 |
| 196 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 12.0385552 |
| 197 | cellular extravasation (GO:0045123) | 10.4248831 |
| 198 | protoporphyrinogen IX metabolic process (GO:0046501) | 10.1252175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.05702945 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.85338910 |
| 3 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 4.46645981 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.71391114 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.34223287 |
| 6 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.21954674 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09432508 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.97042209 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.89568405 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.89568405 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82322294 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.78893362 |
| 13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.78156071 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77539421 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.70934911 |
| 16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.52828589 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.52377128 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49614932 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45799886 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45306639 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37726575 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.37041113 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36120086 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24993697 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.19344082 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19003401 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14612935 |
| 28 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.08916319 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.08703147 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03072358 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99393228 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.94648192 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94261323 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.81422611 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79961579 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77494593 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.72822052 |
| 38 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72481829 |
| 39 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.70670889 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70381784 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67989247 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65963618 |
| 43 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.65855331 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.64940365 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63060871 |
| 46 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.61915800 |
| 47 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.61268190 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.59291758 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.58912599 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58614328 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.56892671 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55509318 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.55073085 |
| 54 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.52963266 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51762147 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.51686043 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.50651185 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48868995 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47735738 |
| 60 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.46297023 |
| 61 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.45327895 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44358324 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42749628 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41455687 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40757586 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40337129 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38561511 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37815145 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36303949 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36063533 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34101871 |
| 72 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.32218586 |
| 73 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.30874610 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30580303 |
| 75 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30413453 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30339999 |
| 77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.30206441 |
| 78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30131958 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27842050 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26756053 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26491473 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26431844 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26262860 |
| 84 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25002973 |
| 85 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.24249150 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23957782 |
| 87 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.22909859 |
| 88 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22138467 |
| 89 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21345547 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20866996 |
| 91 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20408545 |
| 92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.20275636 |
| 93 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.18081987 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.17803260 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17666823 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16781339 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15875502 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15599084 |
| 99 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.13648130 |
| 100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.13630434 |
| 101 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.12698067 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12477286 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12169692 |
| 104 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11985854 |
| 105 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11160783 |
| 106 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11017942 |
| 107 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10802554 |
| 108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10636182 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09075760 |
| 110 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08881642 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08591222 |
| 112 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07948662 |
| 113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07877131 |
| 114 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.07498941 |
| 115 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07306837 |
| 116 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07101890 |
| 117 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06332994 |
| 118 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05749864 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05645576 |
| 120 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04506401 |
| 121 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.04258713 |
| 122 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03697858 |
| 123 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02949624 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02771303 |
| 125 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.02551479 |
| 126 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02179535 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 1.00167880 |
| 128 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99897529 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98850129 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98280746 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.98089653 |
| 132 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97220934 |
| 133 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97053498 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96771150 |
| 135 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96010057 |
| 136 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95820047 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93990653 |
| 138 | AR_19668381_ChIP-Seq_PC3_Human | 0.93837712 |
| 139 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92696026 |
| 140 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91895013 |
| 141 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91238520 |
| 142 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90662210 |
| 143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90514147 |
| 144 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89593843 |
| 145 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89532998 |
| 146 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86808332 |
| 147 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85577067 |
| 148 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.84792766 |
| 149 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84269162 |
| 150 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84157426 |
| 151 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82159518 |
| 152 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.81440126 |
| 153 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.79963029 |
| 154 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78785368 |
| 155 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.78684688 |
| 156 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.78281511 |
| 157 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77747621 |
| 158 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77469338 |
| 159 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.77417563 |
| 160 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.76929499 |
| 161 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76900874 |
| 162 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76611606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 9.38732830 |
| 2 | MP0005670_abnormal_white_adipose | 7.09299263 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.23481393 |
| 4 | MP0000003_abnormal_adipose_tissue | 3.26741659 |
| 5 | MP0005365_abnormal_bile_salt | 3.24293861 |
| 6 | MP0005375_adipose_tissue_phenotype | 3.15364763 |
| 7 | MP0003122_maternal_imprinting | 3.06069512 |
| 8 | MP0003123_paternal_imprinting | 3.02444085 |
| 9 | MP0005666_abnormal_adipose_tissue | 3.01780366 |
| 10 | MP0004858_abnormal_nervous_system | 2.97757386 |
| 11 | MP0003787_abnormal_imprinting | 2.91023314 |
| 12 | MP0006138_congestive_heart_failure | 2.81953734 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.79058230 |
| 14 | MP0004270_analgesia | 2.78389250 |
| 15 | MP0008058_abnormal_DNA_repair | 2.73161673 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.62119087 |
| 17 | MP0001299_abnormal_eye_distance/ | 2.51097068 |
| 18 | MP0009115_abnormal_fat_cell | 2.47302048 |
| 19 | MP0002102_abnormal_ear_morphology | 2.38642205 |
| 20 | MP0003252_abnormal_bile_duct | 2.38114370 |
| 21 | MP0005187_abnormal_penis_morphology | 2.37340774 |
| 22 | MP0003303_peritoneal_inflammation | 2.30971438 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.24848584 |
| 24 | MP0000750_abnormal_muscle_regeneration | 2.24680621 |
| 25 | MP0002009_preneoplasia | 2.24528587 |
| 26 | MP0003880_abnormal_central_pattern | 2.24463340 |
| 27 | MP0010329_abnormal_lipoprotein_level | 2.22951157 |
| 28 | MP0004043_abnormal_pH_regulation | 2.20776772 |
| 29 | MP0002970_abnormal_white_adipose | 2.19712730 |
| 30 | MP0002735_abnormal_chemical_nociception | 2.18416017 |
| 31 | MP0009046_muscle_twitch | 2.14232332 |
| 32 | MP0009745_abnormal_behavioral_response | 2.13963116 |
| 33 | MP0000751_myopathy | 2.12146359 |
| 34 | MP0005334_abnormal_fat_pad | 2.09864628 |
| 35 | MP0003121_genomic_imprinting | 2.07434166 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 2.06643823 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 2.02365202 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.94705608 |
| 39 | MP0005330_cardiomyopathy | 1.93951572 |
| 40 | MP0002064_seizures | 1.92293746 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.90927914 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.85551352 |
| 43 | MP0001486_abnormal_startle_reflex | 1.75475732 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.71119940 |
| 45 | MP0004133_heterotaxia | 1.71048113 |
| 46 | MP0003567_abnormal_fetal_cardiomyocyte | 1.70177252 |
| 47 | MP0003959_abnormal_lean_body | 1.70092833 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.67203423 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.63856353 |
| 50 | MP0000778_abnormal_nervous_system | 1.62878880 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.58784857 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.58271666 |
| 53 | MP0000537_abnormal_urethra_morphology | 1.58135103 |
| 54 | MP0001968_abnormal_touch/_nociception | 1.56620609 |
| 55 | MP0005448_abnormal_energy_balance | 1.55100038 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.54760499 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.53240105 |
| 58 | MP0003329_amyloid_beta_deposits | 1.53099980 |
| 59 | MP0004130_abnormal_muscle_cell | 1.52632160 |
| 60 | MP0002751_abnormal_autonomic_nervous | 1.51749664 |
| 61 | MP0002184_abnormal_innervation | 1.49884406 |
| 62 | MP0000516_abnormal_urinary_system | 1.47367934 |
| 63 | MP0005367_renal/urinary_system_phenotyp | 1.47367934 |
| 64 | MP0008872_abnormal_physiological_respon | 1.47165666 |
| 65 | MP0004084_abnormal_cardiac_muscle | 1.46523980 |
| 66 | MP0001727_abnormal_embryo_implantation | 1.43915077 |
| 67 | MP0002734_abnormal_mechanical_nocicepti | 1.42987063 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.42411616 |
| 69 | MP0001188_hyperpigmentation | 1.42095802 |
| 70 | MP0001529_abnormal_vocalization | 1.39671652 |
| 71 | MP0004885_abnormal_endolymph | 1.38144395 |
| 72 | MP0001970_abnormal_pain_threshold | 1.32175928 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.28843340 |
| 74 | MP0004085_abnormal_heartbeat | 1.27292716 |
| 75 | MP0002118_abnormal_lipid_homeostasis | 1.27111650 |
| 76 | MP0008057_abnormal_DNA_replication | 1.22179786 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 1.21033220 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 1.18816701 |
| 79 | MP0004811_abnormal_neuron_physiology | 1.17211449 |
| 80 | MP0005423_abnormal_somatic_nervous | 1.15918963 |
| 81 | MP0002272_abnormal_nervous_system | 1.14112334 |
| 82 | MP0005452_abnormal_adipose_tissue | 1.13308748 |
| 83 | MP0001440_abnormal_grooming_behavior | 1.11896873 |
| 84 | MP0006276_abnormal_autonomic_nervous | 1.11892020 |
| 85 | MP0005503_abnormal_tendon_morphology | 1.11002058 |
| 86 | MP0002972_abnormal_cardiac_muscle | 1.10250422 |
| 87 | MP0004510_myositis | 1.09875939 |
| 88 | MP0002332_abnormal_exercise_endurance | 1.08903304 |
| 89 | MP0005535_abnormal_body_temperature | 1.07809148 |
| 90 | MP0005266_abnormal_metabolism | 1.05762639 |
| 91 | MP0000538_abnormal_urinary_bladder | 1.05566639 |
| 92 | MP0004484_altered_response_of | 1.04824260 |
| 93 | MP0002822_catalepsy | 1.02898851 |
| 94 | MP0001270_distended_abdomen | 1.02172687 |
| 95 | MP0000955_abnormal_spinal_cord | 1.02030615 |
| 96 | MP0003137_abnormal_impulse_conducting | 1.00511944 |
| 97 | MP0002067_abnormal_sensory_capabilities | 1.00406880 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.97940341 |
| 99 | MP0008569_lethality_at_weaning | 0.96812260 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.96504368 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.94618192 |
| 102 | MP0001340_abnormal_eyelid_morphology | 0.94080632 |
| 103 | MP0008007_abnormal_cellular_replicative | 0.93548061 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.93530274 |
| 105 | MP0002152_abnormal_brain_morphology | 0.92671138 |
| 106 | MP0000733_abnormal_muscle_development | 0.92646896 |
| 107 | MP0000579_abnormal_nail_morphology | 0.91516401 |
| 108 | MP0002066_abnormal_motor_capabilities/c | 0.91137757 |
| 109 | MP0009672_abnormal_birth_weight | 0.90378398 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.89643126 |
| 111 | MP0003879_abnormal_hair_cell | 0.89563285 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.89400996 |
| 113 | MP0001544_abnormal_cardiovascular_syste | 0.89400996 |
| 114 | MP0004742_abnormal_vestibular_system | 0.88866596 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.88018808 |
| 116 | MP0004087_abnormal_muscle_fiber | 0.87478830 |
| 117 | MP0002971_abnormal_brown_adipose | 0.86862095 |
| 118 | MP0000759_abnormal_skeletal_muscle | 0.86247146 |
| 119 | MP0003868_abnormal_feces_composition | 0.86168034 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.86054700 |
| 121 | MP0003828_pulmonary_edema | 0.85080124 |
| 122 | MP0005451_abnormal_body_composition | 0.84567445 |
| 123 | MP0005386_behavior/neurological_phenoty | 0.83890418 |
| 124 | MP0004924_abnormal_behavior | 0.83890418 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.83196263 |
| 126 | MP0003045_fibrosis | 0.81916984 |
| 127 | MP0002882_abnormal_neuron_morphology | 0.81199964 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.81095195 |
| 129 | MP0004145_abnormal_muscle_electrophysio | 0.79757234 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.78908214 |
| 131 | MP0005248_abnormal_Harderian_gland | 0.78321846 |
| 132 | MP0005197_abnormal_uvea_morphology | 0.78014088 |
| 133 | MP0003948_abnormal_gas_homeostasis | 0.76941510 |
| 134 | MP0002106_abnormal_muscle_physiology | 0.76497733 |
| 135 | MP0002736_abnormal_nociception_after | 0.76090596 |
| 136 | MP0002108_abnormal_muscle_morphology | 0.75525474 |
| 137 | MP0005166_decreased_susceptibility_to | 0.75448857 |
| 138 | MP0003075_altered_response_to | 0.75104357 |
| 139 | MP0008438_abnormal_cutaneous_collagen | 0.74844667 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.74240264 |
| 141 | MP0003385_abnormal_body_wall | 0.74013905 |
| 142 | MP0001905_abnormal_dopamine_level | 0.70687228 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.70384945 |
| 144 | MP0002069_abnormal_eating/drinking_beha | 0.66365790 |
| 145 | MP0002269_muscular_atrophy | 0.64403867 |
| 146 | MP0009643_abnormal_urine_homeostasis | 0.64388102 |
| 147 | MP0000343_altered_response_to | 0.62041482 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58062193 |
| 149 | MP0005369_muscle_phenotype | 0.54614388 |
| 150 | MP0003953_abnormal_hormone_level | 0.53974799 |
| 151 | MP0000598_abnormal_liver_morphology | 0.52701010 |
| 152 | MP0008874_decreased_physiological_sensi | 0.51100783 |
| 153 | MP0002419_abnormal_innate_immunity | 0.49041843 |
| 154 | MP0000249_abnormal_blood_vessel | 0.48508034 |
| 155 | MP0009703_decreased_birth_body | 0.48130657 |
| 156 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48081647 |
| 157 | MP0004782_abnormal_surfactant_physiolog | 0.47044546 |
| 158 | MP0001664_abnormal_digestion | 0.38158578 |
| 159 | MP0010307_abnormal_tumor_latency | 0.37826147 |
| 160 | MP0003786_premature_aging | 0.36343733 |
| 161 | MP0010630_abnormal_cardiac_muscle | 0.35930840 |
| 162 | MP0002877_abnormal_melanocyte_morpholog | 0.35559851 |
| 163 | MP0003011_delayed_dark_adaptation | 0.35338013 |
| 164 | MP0002249_abnormal_larynx_morphology | 0.33044482 |
| 165 | MP0000609_abnormal_liver_physiology | 0.32909021 |
| 166 | MP0000681_abnormal_thyroid_gland | 0.31613101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Turricephaly (HP:0000262) | 6.56668224 |
| 2 | Neonatal hypoglycemia (HP:0001998) | 6.02796900 |
| 3 | Abnormality of homocysteine metabolism (HP:0010919) | 5.60650000 |
| 4 | Homocystinuria (HP:0002156) | 5.60650000 |
| 5 | Split foot (HP:0001839) | 5.58808802 |
| 6 | Oligodactyly (HP:0012165) | 5.39088554 |
| 7 | Oligodactyly (hands) (HP:0001180) | 5.06231452 |
| 8 | Focal motor seizures (HP:0011153) | 4.70993597 |
| 9 | Abnormality of the prostate (HP:0008775) | 4.66517621 |
| 10 | Generalized hyperpigmentation (HP:0007440) | 4.48666068 |
| 11 | Failure to thrive in infancy (HP:0001531) | 4.42983827 |
| 12 | Protruding tongue (HP:0010808) | 4.30922801 |
| 13 | Myokymia (HP:0002411) | 4.14997207 |
| 14 | Natal tooth (HP:0000695) | 4.11718324 |
| 15 | Choanal stenosis (HP:0000452) | 3.95587891 |
| 16 | Long toe (HP:0010511) | 3.92556244 |
| 17 | Ureteral stenosis (HP:0000071) | 3.89050345 |
| 18 | Increased muscle lipid content (HP:0009058) | 3.86205680 |
| 19 | Mixed hearing impairment (HP:0000410) | 3.86200721 |
| 20 | Papilledema (HP:0001085) | 3.74425627 |
| 21 | Ureteral obstruction (HP:0006000) | 3.72754629 |
| 22 | Focal seizures (HP:0007359) | 3.58521930 |
| 23 | Absent hand (HP:0004050) | 3.53408172 |
| 24 | Aqueductal stenosis (HP:0002410) | 3.45910192 |
| 25 | Progressive inability to walk (HP:0002505) | 3.37719345 |
| 26 | Neonatal death (HP:0003811) | 3.37136031 |
| 27 | Striae distensae (HP:0001065) | 3.29870873 |
| 28 | Cutaneous photosensitivity (HP:0000992) | 3.19770774 |
| 29 | Pheochromocytoma (HP:0002666) | 3.18859175 |
| 30 | Abnormality of the parathyroid morphology (HP:0011766) | 3.12557485 |
| 31 | Macroorchidism (HP:0000053) | 3.11119416 |
| 32 | Thrombocytosis (HP:0001894) | 3.09612830 |
| 33 | Back pain (HP:0003418) | 3.07726263 |
| 34 | Mutism (HP:0002300) | 3.06441982 |
| 35 | Obstructive lung disease (HP:0006536) | 3.04104785 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04104785 |
| 37 | Hypothermia (HP:0002045) | 3.03370749 |
| 38 | Increased intramyocellular lipid droplets (HP:0012240) | 3.00586170 |
| 39 | Coronal craniosynostosis (HP:0004440) | 2.98391859 |
| 40 | Hypertriglyceridemia (HP:0002155) | 2.97864648 |
| 41 | Chest pain (HP:0100749) | 2.93436405 |
| 42 | Unilateral renal agenesis (HP:0000122) | 2.85836219 |
| 43 | Neoplasm of the adrenal cortex (HP:0100641) | 2.84668806 |
| 44 | Relative macrocephaly (HP:0004482) | 2.81891418 |
| 45 | Enlarged penis (HP:0000040) | 2.81824662 |
| 46 | Round ear (HP:0100830) | 2.79408190 |
| 47 | Visual hallucinations (HP:0002367) | 2.78719437 |
| 48 | Psychosis (HP:0000709) | 2.75557869 |
| 49 | Agitation (HP:0000713) | 2.73005235 |
| 50 | Infantile muscular hypotonia (HP:0008947) | 2.71818392 |
| 51 | Porencephaly (HP:0002132) | 2.66697562 |
| 52 | Dysmetric saccades (HP:0000641) | 2.60721051 |
| 53 | Action tremor (HP:0002345) | 2.55745342 |
| 54 | Advanced eruption of teeth (HP:0006288) | 2.53978119 |
| 55 | Hemiplegia (HP:0002301) | 2.53886699 |
| 56 | Abnormality of male internal genitalia (HP:0000022) | 2.52374118 |
| 57 | Renal Fanconi syndrome (HP:0001994) | 2.52372287 |
| 58 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.52256362 |
| 59 | Bilateral microphthalmos (HP:0007633) | 2.50850976 |
| 60 | Facial shape deformation (HP:0011334) | 2.47227877 |
| 61 | Potter facies (HP:0002009) | 2.47227877 |
| 62 | Cheilitis (HP:0100825) | 2.45093295 |
| 63 | Hyperlipoproteinemia (HP:0010980) | 2.44951262 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.44463471 |
| 65 | Clumsiness (HP:0002312) | 2.43516119 |
| 66 | Epidermoid cyst (HP:0200040) | 2.43420535 |
| 67 | External ophthalmoplegia (HP:0000544) | 2.42974939 |
| 68 | Tubulointerstitial fibrosis (HP:0005576) | 2.42754299 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.42632619 |
| 70 | Partial agenesis of the corpus callosum (HP:0001338) | 2.39977106 |
| 71 | Absent speech (HP:0001344) | 2.37031076 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.35053083 |
| 73 | Prostate neoplasm (HP:0100787) | 2.35041401 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.34606889 |
| 75 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.33388483 |
| 76 | Athetosis (HP:0002305) | 2.32191063 |
| 77 | Genetic anticipation (HP:0003743) | 2.29224358 |
| 78 | Acanthosis nigricans (HP:0000956) | 2.29110551 |
| 79 | Periorbital edema (HP:0100539) | 2.28527040 |
| 80 | Orthostatic hypotension (HP:0001278) | 2.26672043 |
| 81 | Progressive microcephaly (HP:0000253) | 2.26430136 |
| 82 | Polycythemia (HP:0001901) | 2.23501429 |
| 83 | Generalized tonic-clonic seizures (HP:0002069) | 2.22563271 |
| 84 | Large earlobe (HP:0009748) | 2.19981416 |
| 85 | Excessive salivation (HP:0003781) | 2.19628167 |
| 86 | Drooling (HP:0002307) | 2.19628167 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.18864822 |
| 88 | Annular pancreas (HP:0001734) | 2.18676694 |
| 89 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.18210755 |
| 90 | Sudden death (HP:0001699) | 2.17667122 |
| 91 | Abnormality of chloride homeostasis (HP:0011422) | 2.16815399 |
| 92 | Thyroid carcinoma (HP:0002890) | 2.16740261 |
| 93 | Abdominal pain (HP:0002027) | 2.16319457 |
| 94 | Flat occiput (HP:0005469) | 2.16177665 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.15914685 |
| 96 | Abnormality of glycolysis (HP:0004366) | 2.15632303 |
| 97 | Abnormality of macular pigmentation (HP:0008002) | 2.14833581 |
| 98 | Thin skin (HP:0000963) | 2.14788973 |
| 99 | Adducted thumb (HP:0001181) | 2.14395400 |
| 100 | Adrenal overactivity (HP:0002717) | 2.14127821 |
| 101 | Absence seizures (HP:0002121) | 2.13729884 |
| 102 | Facial edema (HP:0000282) | 2.12892787 |
| 103 | Protrusio acetabuli (HP:0003179) | 2.11908882 |
| 104 | Hyperthyroidism (HP:0000836) | 2.11135895 |
| 105 | Exercise-induced myalgia (HP:0003738) | 2.10946503 |
| 106 | Increased serum pyruvate (HP:0003542) | 2.09547107 |
| 107 | High anterior hairline (HP:0009890) | 2.08998969 |
| 108 | Mesangial abnormality (HP:0001966) | 2.08424761 |
| 109 | Limited elbow extension (HP:0001377) | 2.07502111 |
| 110 | Plagiocephaly (HP:0001357) | 2.07163359 |
| 111 | Split hand (HP:0001171) | 2.03388208 |
| 112 | Tubulointerstitial abnormality (HP:0001969) | 2.03266670 |
| 113 | Skull defect (HP:0001362) | 2.02862043 |
| 114 | Inability to walk (HP:0002540) | 2.02330680 |
| 115 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00626887 |
| 116 | Exertional dyspnea (HP:0002875) | 1.99631010 |
| 117 | Amblyopia (HP:0000646) | 1.99195830 |
| 118 | Breech presentation (HP:0001623) | 1.98798572 |
| 119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98715942 |
| 120 | Epileptic encephalopathy (HP:0200134) | 1.98209190 |
| 121 | Calcaneovalgus deformity (HP:0001848) | 1.97809786 |
| 122 | Lipid accumulation in hepatocytes (HP:0006561) | 1.96174667 |
| 123 | Renal cell carcinoma (HP:0005584) | 1.95801897 |
| 124 | Malnutrition (HP:0004395) | 1.95153796 |
| 125 | Depression (HP:0000716) | 1.94456578 |
| 126 | Microvesicular hepatic steatosis (HP:0001414) | 1.94448620 |
| 127 | Termporal pattern (HP:0011008) | 1.93586206 |
| 128 | Insidious onset (HP:0003587) | 1.93586206 |
| 129 | Disproportionate tall stature (HP:0001519) | 1.93564797 |
| 130 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93452572 |
| 131 | Metabolic alkalosis (HP:0200114) | 1.92618151 |
| 132 | Hypoventilation (HP:0002791) | 1.92535431 |
| 133 | Absent toe (HP:0010760) | 1.91674425 |
| 134 | Cerebral hemorrhage (HP:0001342) | 1.91228124 |
| 135 | Myotonia (HP:0002486) | 1.90897517 |
| 136 | Severe global developmental delay (HP:0011344) | 1.90673845 |
| 137 | Sporadic (HP:0003745) | 1.90241636 |
| 138 | Long foot (HP:0001833) | 1.89550165 |
| 139 | Restlessness (HP:0000711) | 1.89228836 |
| 140 | Subacute progressive viral hepatitis (HP:0006572) | 1.88861052 |
| 141 | Death in childhood (HP:0003819) | 1.88351760 |
| 142 | Skin nodule (HP:0200036) | 1.88099236 |
| 143 | Pointed chin (HP:0000307) | 1.87272365 |
| 144 | Fair hair (HP:0002286) | 1.86068041 |
| 145 | Limb dystonia (HP:0002451) | 1.85882035 |
| 146 | Stereotypic behavior (HP:0000733) | 1.85859001 |
| 147 | Adactyly (HP:0009776) | 1.85428641 |
| 148 | Fragile skin (HP:0001030) | 1.84862403 |
| 149 | Difficulty running (HP:0009046) | 1.83583808 |
| 150 | Cerebral inclusion bodies (HP:0100314) | 1.83495032 |
| 151 | Aplasia involving bones of the extremities (HP:0009825) | 1.83490425 |
| 152 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83490425 |
| 153 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83490425 |
| 154 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.83321972 |
| 155 | Hypercortisolism (HP:0001578) | 1.83068068 |
| 156 | Onycholysis (HP:0001806) | 1.82547654 |
| 157 | Hepatocellular carcinoma (HP:0001402) | 1.82391806 |
| 158 | Broad distal phalanx of finger (HP:0009836) | 1.80737721 |
| 159 | Buphthalmos (HP:0000557) | 1.80553551 |
| 160 | Hypokalemic alkalosis (HP:0001949) | 1.80473828 |
| 161 | Bicornuate uterus (HP:0000813) | 1.79353206 |
| 162 | Hyperparathyroidism (HP:0000843) | 1.76850282 |
| 163 | Primary atrial arrhythmia (HP:0001692) | 1.76644603 |
| 164 | Upper motor neuron abnormality (HP:0002127) | 1.76529468 |
| 165 | Atrial fibrillation (HP:0005110) | 1.75724758 |
| 166 | Small hand (HP:0200055) | 1.73489054 |
| 167 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73324099 |
| 168 | Obstructive sleep apnea (HP:0002870) | 1.71986750 |
| 169 | Inappropriate behavior (HP:0000719) | 1.71675379 |
| 170 | Ventricular fibrillation (HP:0001663) | 1.71668084 |
| 171 | Spinal cord compression (HP:0002176) | 1.70466383 |
| 172 | Lower limb amyotrophy (HP:0007210) | 1.69776606 |
| 173 | Hyperventilation (HP:0002883) | 1.69549073 |
| 174 | Narrow nasal bridge (HP:0000446) | 1.69271041 |
| 175 | Broad-based gait (HP:0002136) | 1.68402781 |
| 176 | Exotropia (HP:0000577) | 1.68076982 |
| 177 | Abnormality of the lower motor neuron (HP:0002366) | 1.67978303 |
| 178 | Stroke (HP:0001297) | 1.67523660 |
| 179 | Poor eye contact (HP:0000817) | 1.65412409 |
| 180 | Protruding ear (HP:0000411) | 1.64099392 |
| 181 | Supraventricular tachycardia (HP:0004755) | 1.63736933 |
| 182 | Dialeptic seizures (HP:0011146) | 1.63498364 |
| 183 | Torticollis (HP:0000473) | 1.63051908 |
| 184 | Bronchomalacia (HP:0002780) | 1.62950374 |
| 185 | Hypophosphatemia (HP:0002148) | 1.62449719 |
| 186 | Supraventricular arrhythmia (HP:0005115) | 1.62027244 |
| 187 | Incomplete penetrance (HP:0003829) | 1.61974936 |
| 188 | Neurofibrillary tangles (HP:0002185) | 1.61900269 |
| 189 | Recurrent cutaneous fungal infections (HP:0011370) | 1.61324916 |
| 190 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.61324916 |
| 191 | Anxiety (HP:0000739) | 1.59132074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CCNB1 | 7.70570683 |
| 2 | PINK1 | 7.41873312 |
| 3 | NEK2 | 6.66312953 |
| 4 | DAPK2 | 5.62122524 |
| 5 | CAMK1D | 4.97516895 |
| 6 | MAPK7 | 4.76562390 |
| 7 | CAMKK2 | 4.68867951 |
| 8 | PRPF4B | 4.66674224 |
| 9 | SMG1 | 4.28610468 |
| 10 | CAMK1G | 3.43512023 |
| 11 | TESK2 | 3.10318354 |
| 12 | TAF1 | 3.09679662 |
| 13 | VRK2 | 3.07387378 |
| 14 | MARK1 | 2.92782171 |
| 15 | RPS6KL1 | 2.87319821 |
| 16 | RPS6KC1 | 2.87319821 |
| 17 | TAOK2 | 2.72175068 |
| 18 | RPS6KA6 | 2.49187818 |
| 19 | DAPK1 | 2.40685274 |
| 20 | NTRK3 | 2.09937134 |
| 21 | EPHB2 | 2.06504510 |
| 22 | LRRK2 | 1.87239102 |
| 23 | ICK | 1.86467835 |
| 24 | MST1R | 1.58292413 |
| 25 | DAPK3 | 1.56528396 |
| 26 | PHKG2 | 1.52442134 |
| 27 | PHKG1 | 1.52442134 |
| 28 | EPHA4 | 1.46571611 |
| 29 | MAP3K9 | 1.39151525 |
| 30 | MAP3K7 | 1.36710770 |
| 31 | CLK1 | 1.30701727 |
| 32 | CASK | 1.28612869 |
| 33 | KSR2 | 1.26378004 |
| 34 | CHUK | 1.21978196 |
| 35 | TRIB3 | 1.20628216 |
| 36 | AKT3 | 1.16530762 |
| 37 | IRAK3 | 1.15364479 |
| 38 | LATS2 | 1.10909822 |
| 39 | PAK6 | 1.08099604 |
| 40 | NTRK2 | 1.05040674 |
| 41 | WNK4 | 1.04193252 |
| 42 | MINK1 | 1.00828522 |
| 43 | PLK4 | 1.00199759 |
| 44 | TESK1 | 0.98901148 |
| 45 | ERN1 | 0.97753827 |
| 46 | MAP3K2 | 0.96643023 |
| 47 | GRK5 | 0.95289978 |
| 48 | PRKAA2 | 0.95194947 |
| 49 | MAPK4 | 0.92973252 |
| 50 | EEF2K | 0.92244191 |
| 51 | CAMK1 | 0.86107295 |
| 52 | SIK1 | 0.82088623 |
| 53 | SIK2 | 0.75824037 |
| 54 | MTOR | 0.75148448 |
| 55 | TTN | 0.72320504 |
| 56 | LMTK2 | 0.70440823 |
| 57 | CDK5 | 0.69839161 |
| 58 | MAP3K4 | 0.69755923 |
| 59 | RIPK1 | 0.69742895 |
| 60 | PRKD3 | 0.67749548 |
| 61 | MAPK9 | 0.66846118 |
| 62 | STK11 | 0.63279396 |
| 63 | PAK3 | 0.63104184 |
| 64 | MUSK | 0.62663557 |
| 65 | RET | 0.61935446 |
| 66 | UHMK1 | 0.61704598 |
| 67 | TYRO3 | 0.61143098 |
| 68 | BMX | 0.60847276 |
| 69 | YES1 | 0.58646880 |
| 70 | MAPK12 | 0.58377716 |
| 71 | PDGFRB | 0.58162199 |
| 72 | NTRK1 | 0.58128809 |
| 73 | CSNK1G2 | 0.56384845 |
| 74 | CDK15 | 0.56381790 |
| 75 | ERBB3 | 0.55491330 |
| 76 | CDK18 | 0.54281342 |
| 77 | PLK2 | 0.52887614 |
| 78 | INSRR | 0.52588637 |
| 79 | CDK14 | 0.51880687 |
| 80 | DYRK2 | 0.51539078 |
| 81 | ERBB4 | 0.51338702 |
| 82 | CSNK1A1L | 0.50785263 |
| 83 | KSR1 | 0.49036793 |
| 84 | CDK11A | 0.49005046 |
| 85 | EIF2AK2 | 0.48583370 |
| 86 | VRK1 | 0.47274578 |
| 87 | MET | 0.47109565 |
| 88 | MARK2 | 0.47089978 |
| 89 | MAPK13 | 0.46790211 |
| 90 | NUAK1 | 0.45659197 |
| 91 | CAMKK1 | 0.44474600 |
| 92 | PRKAA1 | 0.43031854 |
| 93 | PDK3 | 0.42583271 |
| 94 | PDK4 | 0.42583271 |
| 95 | RPS6KB2 | 0.41307391 |
| 96 | PKN2 | 0.40682301 |
| 97 | DDR2 | 0.39832043 |
| 98 | MAP2K3 | 0.39274490 |
| 99 | MAP2K4 | 0.39159877 |
| 100 | ALK | 0.38369329 |
| 101 | CDK9 | 0.37221267 |
| 102 | SYK | 0.36188220 |
| 103 | DMPK | 0.35859331 |
| 104 | RPS6KA3 | 0.35760964 |
| 105 | TAOK1 | 0.35457617 |
| 106 | PAK2 | 0.35167384 |
| 107 | PRKCG | 0.33945257 |
| 108 | PKN1 | 0.32600174 |
| 109 | GRK1 | 0.31242913 |
| 110 | MAPK8 | 0.31113297 |
| 111 | CAMK2A | 0.30037942 |
| 112 | CAMK2B | 0.29732029 |
| 113 | CSNK1G3 | 0.29391566 |
| 114 | PRKCH | 0.28062497 |
| 115 | MELK | 0.27218635 |
| 116 | CAMK2D | 0.27149591 |
| 117 | MAP2K7 | 0.26792695 |
| 118 | MAP3K10 | 0.26448864 |
| 119 | PDPK1 | 0.25964069 |
| 120 | INSR | 0.25443079 |
| 121 | LIMK1 | 0.25121693 |
| 122 | PRKACG | 0.25104771 |
| 123 | CAMK4 | 0.24606077 |
| 124 | PRKACA | 0.24605683 |
| 125 | MAP2K1 | 0.24563459 |
| 126 | DYRK1A | 0.23517252 |
| 127 | TNK2 | 0.22372599 |
| 128 | CAMK2G | 0.21084714 |
| 129 | ABL2 | 0.20341393 |
| 130 | AKT1 | 0.20287805 |
| 131 | PDGFRA | 0.19718156 |
| 132 | FYN | 0.19320045 |
| 133 | SGK1 | 0.19176659 |
| 134 | CSK | 0.18559481 |
| 135 | HIPK2 | 0.18303731 |
| 136 | CSNK1G1 | 0.17700421 |
| 137 | MAPKAPK5 | 0.17489674 |
| 138 | STK4 | 0.16234219 |
| 139 | OBSCN | 0.15952761 |
| 140 | CHEK2 | 0.14821741 |
| 141 | DYRK1B | 0.13994846 |
| 142 | PRKD1 | 0.13899892 |
| 143 | MAP3K11 | 0.12346400 |
| 144 | PTK2 | 0.10695020 |
| 145 | GSK3A | 0.10506318 |
| 146 | CDK3 | 0.10161769 |
| 147 | MAPK14 | 0.09380237 |
| 148 | GSK3B | 0.08919475 |
| 149 | FLT3 | 0.07940410 |
| 150 | KIT | 0.07358331 |
| 151 | WNK1 | 0.06921981 |
| 152 | CDK7 | 0.06309898 |
| 153 | CDK6 | 0.06005616 |
| 154 | CDK4 | 0.05934334 |
| 155 | MAP2K2 | 0.05733455 |
| 156 | CDK2 | 0.05664852 |
| 157 | CSNK1E | 0.05253315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pyruvate metabolism_Homo sapiens_hsa00620 | 3.99793673 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.92734616 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.50768747 |
| 4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.92469728 |
| 5 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.77727121 |
| 6 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.71238670 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 2.68951172 |
| 8 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.65287247 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.61374945 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.52621519 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.44192468 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.41974857 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.38194268 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.19161026 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 2.04956967 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.97717882 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.95462687 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.94924522 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.88701542 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.79935803 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78598286 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.78468062 |
| 23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.74439753 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67103573 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63864187 |
| 26 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.61888870 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.56516771 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55509129 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.54129401 |
| 30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.52654514 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.52466885 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51938390 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47913565 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.47344310 |
| 35 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.47176478 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.47063486 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46897311 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46408054 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.46116852 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 1.45276776 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.43831630 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.41672783 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.40996590 |
| 44 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.39872262 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39785089 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.37710533 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37700390 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.37472270 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.36738240 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.35134890 |
| 51 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33636752 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 1.30762364 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29842033 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 1.28465490 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.25549639 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20605521 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 1.20290835 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.19047945 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16687398 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16206926 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.15272514 |
| 62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.15159309 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14724988 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13167157 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12373379 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12254102 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 1.11466667 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09954875 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08870233 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.08310454 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 1.05305966 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04356915 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03097969 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02252411 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 1.01036437 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96012869 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95587733 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94369238 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94305389 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93292758 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93219367 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.93206857 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92220209 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88687419 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88519075 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86534594 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85539054 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.85329610 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85058328 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84202984 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82837216 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82554145 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82022960 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81748187 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81020332 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80124510 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.79166077 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78637889 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77460408 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77292286 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.76288814 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75650923 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.75230334 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.75063435 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.74772027 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74532013 |
| 107 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.74487167 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73275740 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.71798883 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71578738 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70779049 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70758818 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68387092 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68366282 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68029474 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67608716 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65261254 |
| 118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63921320 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63639481 |
| 120 | Phototransduction_Homo sapiens_hsa04744 | 0.62260350 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61139720 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59532933 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.59523380 |
| 124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58632191 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58307400 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58151655 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57548629 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57498217 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57402604 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57287358 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57207631 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56114808 |
| 133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53314986 |
| 134 | Adherens junction_Homo sapiens_hsa04520 | 0.52973119 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52622443 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52378023 |
| 137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52369618 |
| 138 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50881970 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50170270 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49964955 |
| 141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48941561 |
| 142 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48720644 |
| 143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48418884 |
| 144 | Phagosome_Homo sapiens_hsa04145 | 0.47880587 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.46958621 |
| 146 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46587101 |
| 147 | Tight junction_Homo sapiens_hsa04530 | 0.45627685 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44729918 |
| 149 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43251407 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42581515 |
| 151 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40403778 |
| 152 | Bladder cancer_Homo sapiens_hsa05219 | 0.40360862 |
| 153 | Ribosome_Homo sapiens_hsa03010 | 0.38434750 |
| 154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35415229 |
| 155 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31029864 |
| 156 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28999106 |
| 157 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28065576 |

